Characterization of Microrna Expression Profiles Associated with Hepatitis B Virus Replication and Clearance in Vivo and in Vitro

Xiao-Ben Pan,Hui Ma,Qian Jin,Lai Wei
DOI: https://doi.org/10.1111/j.1440-1746.2011.06979.x
2012-01-01
Journal of Gastroenterology and Hepatology
Abstract:Background and Aim: Alpha interferon (IFN-alpha) is an approved treatment for chronic hepatitis B (CHB). MicroRNA (miRNA) are currently known as a part of IFN-mediated antiviral defense. We aimed at characterizing the miRNA expression associated with hepatitis B virus (HBV) replication and IFN-mediated HBV clearance.Methods: We investigated the expression patterns of cellular miRNA induced by HBV replication and/or IFN-alpha treatment in HepG2 cells, and also analyzed the miRNA response in peripheral blood mononuclear cells in CHB patients on IFN-a treatment. The differentially expressed miRNA were verified using quantitative real-time polymerase chain reaction and an miRNA expression pattern was classified based on the final virological response.Results: A total of 223 miRNA were differentially expressed (> 1.5 folds) between the HepG2.2.15 and HepG2 cells, including 24 highly differentially expressed miRNA (> 5 folds). With 12 h of IFN-alpha, treatment, 23 totally differentially expressed miRNA were identified in HepG2 cells; whereas only five miRNA were identified in HepG2.2.15 cells. Similar amounts of the miRNA were regulated in patients with HBeAg or non-HBeAg seroconversion; whereas levels of eight miRNA were significantly differentially expressed between the two groups.Conclusions: HBV replication alters miRNA expression profiles and impairs IFN-inducible miRNA response in HepG2 cells. The miRNA expression pattern of peripheral blood mononuclear cells in CHB patients with ITN therapy can be associated with their therapeutic outcome.
What problem does this paper attempt to address?